Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Chagas Disease Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Chagas Disease Drugmarket, defines the market attractiveness level of Chagas Disease Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Chagas Disease Drug industry, describes the types of Chagas Disease Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chagas Disease Drug market and the development prospects and opportunities of Chagas Disease Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chagas Disease Drug market in Chapter 13.
By Player:
Oblita Therapeutics BVBA
Humanigen Inc
Grupo Praxis Pharmaceutical SA
Eisai Co Ltd
AstraZeneca Plc
Sanofi
GlaxoSmithKline Plc
Kancera AB
Daiichi Sankyo Co Ltd
Novartis AG
Merck & Co Inc
Bayer AG
By Type:
Cz-007
Cz-008
D-121
DNDI-0690
EPLBS-1246
EPLBS-967
Others
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Chagas Disease Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Chagas Disease Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Chagas Disease Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Chagas Disease Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Chagas Disease Drug Market Analysis and Outlook to 2022
-
7.1 Global Chagas Disease Drug Consumption (2017-2022)
-
7.2 United States Chagas Disease Drug Consumption (2017-2022)
-
7.3 Europe Chagas Disease Drug Consumption (2017-2022)
-
7.4 China Chagas Disease Drug Consumption (2017-2022)
-
7.5 Japan Chagas Disease Drug Consumption (2017-2022)
-
7.6 India Chagas Disease Drug Consumption (2017-2022)
-
7.7 South Korea Chagas Disease Drug Consumption (2017-2022)
8 Region and Country-wise Chagas Disease Drug Market Analysis and Outlook to 2028
-
8.1 Global Chagas Disease Drug Consumption Forecast (2022-2028)
-
8.2 United States Chagas Disease Drug Consumption Forecast (2022-2028)
-
8.3 Europe Chagas Disease Drug Consumption Forecast (2022-2028)
-
8.4 China Chagas Disease Drug Consumption Forecast (2022-2028)
-
8.5 Japan Chagas Disease Drug Consumption Forecast (2022-2028)
-
8.6 India Chagas Disease Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Chagas Disease Drug Consumption Forecast (2022-2028)
9 Global Chagas Disease Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Chagas Disease Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Cz-007 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Cz-008 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global D-121 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global DNDI-0690 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global EPLBS-1246 Consumption and Growth Rate (2017-2022)
-
9.1.6 Global EPLBS-967 Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Chagas Disease Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Chagas Disease Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Chagas Disease Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Cz-007 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Cz-008 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global D-121 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global DNDI-0690 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global EPLBS-1246 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global EPLBS-967 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Chagas Disease Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Chagas Disease Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Chagas Disease Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Chagas Disease Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Chagas Disease Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Chagas Disease Drug Market Competitive Analysis
-
14.1 Oblita Therapeutics BVBA
-
14.1.1 Oblita Therapeutics BVBA Company Details
-
14.1.2 Oblita Therapeutics BVBA Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Oblita Therapeutics BVBA Chagas Disease Drug Product and Service
-
14.2 Humanigen Inc
-
14.2.1 Humanigen Inc Company Details
-
14.2.2 Humanigen Inc Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Humanigen Inc Chagas Disease Drug Product and Service
-
14.3 Grupo Praxis Pharmaceutical SA
-
14.3.1 Grupo Praxis Pharmaceutical SA Company Details
-
14.3.2 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product and Service
-
14.4 Eisai Co Ltd
-
14.4.1 Eisai Co Ltd Company Details
-
14.4.2 Eisai Co Ltd Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eisai Co Ltd Chagas Disease Drug Product and Service
-
14.5 AstraZeneca Plc
-
14.5.1 AstraZeneca Plc Company Details
-
14.5.2 AstraZeneca Plc Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AstraZeneca Plc Chagas Disease Drug Product and Service
-
14.6 Sanofi
-
14.6.1 Sanofi Company Details
-
14.6.2 Sanofi Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sanofi Chagas Disease Drug Product and Service
-
14.7 GlaxoSmithKline Plc
-
14.7.1 GlaxoSmithKline Plc Company Details
-
14.7.2 GlaxoSmithKline Plc Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GlaxoSmithKline Plc Chagas Disease Drug Product and Service
-
14.8 Kancera AB
-
14.8.1 Kancera AB Company Details
-
14.8.2 Kancera AB Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Kancera AB Chagas Disease Drug Product and Service
-
14.9 Daiichi Sankyo Co Ltd
-
14.9.1 Daiichi Sankyo Co Ltd Company Details
-
14.9.2 Daiichi Sankyo Co Ltd Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Daiichi Sankyo Co Ltd Chagas Disease Drug Product and Service
-
14.10 Novartis AG
-
14.10.1 Novartis AG Company Details
-
14.10.2 Novartis AG Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Novartis AG Chagas Disease Drug Product and Service
-
14.11 Merck & Co Inc
-
14.11.1 Merck & Co Inc Company Details
-
14.11.2 Merck & Co Inc Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Merck & Co Inc Chagas Disease Drug Product and Service
-
14.12 Bayer AG
-
14.12.1 Bayer AG Company Details
-
14.12.2 Bayer AG Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Bayer AG Chagas Disease Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Chagas Disease Drug
-
Figure Chagas Disease Drug Picture
-
Table Global Chagas Disease Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Chagas Disease Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Chagas Disease Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Chagas Disease Drug Consumption by Country (2017-2022)
-
Figure United States Chagas Disease Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Chagas Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure China Chagas Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Chagas Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure India Chagas Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Chagas Disease Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Chagas Disease Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Chagas Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Chagas Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Chagas Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Chagas Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Chagas Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Chagas Disease Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cz-007 Consumption and Growth Rate (2017-2022)
-
Figure Global Cz-008 Consumption and Growth Rate (2017-2022)
-
Figure Global D-121 Consumption and Growth Rate (2017-2022)
-
Figure Global DNDI-0690 Consumption and Growth Rate (2017-2022)
-
Figure Global EPLBS-1246 Consumption and Growth Rate (2017-2022)
-
Figure Global EPLBS-967 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Cz-007 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cz-008 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global D-121 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DNDI-0690 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global EPLBS-1246 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global EPLBS-967 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Chagas Disease Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Chagas Disease Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Oblita Therapeutics BVBA (Foundation Year, Company Profile and etc.)
-
Table Oblita Therapeutics BVBA Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oblita Therapeutics BVBA Chagas Disease Drug Product and Service
-
Table Humanigen Inc (Foundation Year, Company Profile and etc.)
-
Table Humanigen Inc Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Humanigen Inc Chagas Disease Drug Product and Service
-
Table Grupo Praxis Pharmaceutical SA (Foundation Year, Company Profile and etc.)
-
Table Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product and Service
-
Table Eisai Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Eisai Co Ltd Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Co Ltd Chagas Disease Drug Product and Service
-
Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Plc Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Plc Chagas Disease Drug Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Chagas Disease Drug Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Chagas Disease Drug Product and Service
-
Table Kancera AB (Foundation Year, Company Profile and etc.)
-
Table Kancera AB Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kancera AB Chagas Disease Drug Product and Service
-
Table Daiichi Sankyo Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Co Ltd Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Co Ltd Chagas Disease Drug Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Chagas Disease Drug Product and Service
-
Table Merck & Co Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Inc Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Chagas Disease Drug Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Chagas Disease Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Chagas Disease Drug Product and Service
-
